Synthesis and in vitro leishmanicidal activity of disulfide derivatives

Medicinal Chemistry

Volumn 7, Issue 6, 2011, Pages 704-710

  Khan, Khalid Mohammed ^a   Taha, Muhammad ^a   Naz, Farzana ^a   Khan, Momin ^a   Rahim, Fazal ^a   Samreen, ^a   Perveen, Shahnaz ^b   Choudhary, M Iqbal ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b PCSIR LABORATORIES COMPLEX   (Pakistan)

Author keywords

Disulfides; Leishmanicidal activity; Synthesis

Indexed keywords

ANTILEISHMANIAL AGENT; BIS(2 BENZIMIDAZOLE)DISULFIDE; BIS(2 PYRIDYL)DISULFIDE; BIS(4 HYDROXYPHENYL)DISULFIDE; BIS(4 METHYLPHENYL)DISULFIDE; DISULFIDE; N [2 [[2 (ACETYLAMINO)PHENYL]DISULFANYL]PHENYL]ACETAMIDE; PENTAMIDINE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 80755176746     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340611797928460     Document Type: Article

References (45)

1. Allison, M.J. Leishmaniasis. In: Kiple KF, editor. The Cambridge history of human disease. Cambridge: Cambridge University Press, 1993.
2. Leishaman, W.B. On the possibility of the occurrence of trypanosomiasis in India. Brit. Med. J., 1903, 1, 1252-1254.
3. Donovan, C. On the possibility of the occurrence of trypanosomiasis in India. Brit. Med. J., 1903, 2, 79-82.
4. Nicolle, C.; Comte, C. Origine canine du Kala-azar. Bulletin Société Pathologie Exotique, 1908, 1, 299-301.
5. WHO (World Health Organisation): Communicable disease surveillance and response [http://www.who.int/emc/diseases/leish/leisdis1.html].
6. Croft, S.L. The current status of antiparasite chemotherapy. Parasitology, 1997, 114, S3-S15.
7. Engers, H.D.; Bergquist, R.; Moddaber, F. Progress on vaccines against parasite. Dev. Biol. Stand., 1996, 87, 73-84.
8. Croft, S.L. Recent developments in the chemotherapy of leishmaniasis. Trends Pharmacol. Sci., 1988, 9, 376-381.
9. Berman, J.D. Chemotherapy of leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies. Rev. Infect. Dis., 1988, 10, 560-586.
10. Murray, H.W. Treatment of visceral Leishmaniasis in 2004. Am. J. Trop. Med. Hyg., 2004, 71, 787-794. (Pubitemid 40075632)
11. Khan, K.M.; Rasheed, M.; Zia-Ullah; Hayat, S.; Kaukab, F.; Choudhary, M.I.; Atta-Ur-Rahman; Perveen, S. Synthesis and in vitro leishmanicidal activity of some hydrazides and their analogues. Bioorg. Med. Chem., 2003, 11, 1381-1387; (Pubitemid 36293532)
12. Leena, G.; Naresh, S.; Aditya, V.; Saumya, S.; Suman, G.; Neena, G.; Prem, M.S. C. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b] indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio- pyrimidines against Leishmania donovani. Eur. J. Med. Chem., 2010, 45, 2359-2365;
13. Kumar, R.; Khan, S.; Verma, A.; Srivastava, S.; Viswakarma, P.; Gupta, S.; Meena, S.; Singh, N.; Sarkar, J.; Chauhan, P.M.S.; Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-β-carbolines as antileishmanial agents. Eur. J. Med. Chem., 2010, 45, 3274-3280;
14. Sharad, P.; Chauhan, S.C.; Chauhan, P.M.S.; Shakya, N.; Verma, A.; Gupta, S. Discovery of novel antileishmanial agents in an attempt to synthesize pentamidine-aplysinopsin hybrid molecule. J. Med. Chem., 2009, 52, 5793-5802.
15. Zhai, L.; Chen, M.; Blom, J.; Theander, T. G.; Christensen, S. B.; Kharazmi, A. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J. Antimicrob. Chemother., 1999, 43, 793-803. (Pubitemid 29273729)
16. de Mello, H.; Echevarria, A.; Bernardino, A. M.; Canto-Cavalheiro, M.; Leon, L.L. Antileishmanial pyrazolopyridine derivatives: Synthesis and structure-activity relationship analysis. J. Med. Chem., 2004, 47, 5427-5432. (Pubitemid 39382792)
17. Rodrigues, R.F.; da Silva, E.F.; Echevarria, á.; Fajardo-Bonin, R.; Amaral, V.F.; Leon, L.L.; Canto-Cavalheiro, M.M.A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation. Eur. J. Med. Chem., 2007, 42, 1039-1043. (Pubitemid 46907336)
18. da Silva, E.F.; Canto-Cavalheiro, M.M.; Braz, V.R.; Cysne-Finkelstein, L.; Leon, L. L.; Echevarria, A. Synthesis, and biological evaluation of new 1,3,4-thiazolium-2-phenylamine derivatives against Leishmania amazonensis promastigotes. Eur. J. Med. Chem., 2002, 37, 979-984. (Pubitemid 36355835)
19. Khan K.M.; Mughal, U.R.; Ambeen, N.; Samreen, Perveen, S.; Choudhary, M.I. Synthesis and leishmanical activity of 2,3,4-substituted-5-imidazolones. J. Enzyme Inhib. Med. Chem., 2010, 25, 29-37.
20. Khan, K.M.; Saied, S.; Mughal, U.R.; Munawar, M.; Samreen, Khan, A.; Perveen, S. Synthesis, leishmanicidal and enzyme inhibitory activities of quinoline-4-carboxylic acid. J. Chem. Soc. Pak., 2009, 31, 809-818.
21. Salma, U.; Mazhar, M.; Imtiaz-ud-Din; Ali, S.; Khan K.M. In vitro antileishmanial activities of germatarnyl and silicon incorporated diorganotin derivatives: Synthesis and spectroscopic properties. J. Enzyme Inhib. Med. Chem., 2009, 24, 413-419.
22. Khan, K.M.; Khan, M.Z.; Taha, M.; Maharvi, G.M.; Saify, Z.S.; Perveen, S.; Choudhary, M.I. Leishmanicidal potential of Nsubstituted morpholine derivatives: Synthesis and structure-activity relationships. Nat. Prod. Res., 2009, 23, 479-484.
23. Khan, K.M.; Mughal, U.R.; Samreen; Perveen, S.; Choudhary, M.I. Schiff Bases of Isatin: Potential anti-leishmanial agents. Lett. Drug Design Dis., 2008, 5, 243-249. (Pubitemid 351840264)
24. Caserio, M.C.; Fisher, C.L.; Kim, J.K. Boron trifluoride catalyzed addition of disulfides to alkenes. J. Org. Chem., 1985, 50, 4390-4393.
25. Kitamura, T.; Matsuyuki, J.-I.; Taniguchi, H. 1,2-Disulphenylation of alkenes induced by a hypervalent iodine (III) reagent [PhIOTfOH]. J. Chem. Soc. Perkin Trans., 1991, 1, 1607-1608.
26. Gilliland, D.G.; Collier, R.J.; Moehring, J.M.; Moehring, T.J. Chimeric toxins: Toxic, disulfide-linked conjugate of concanavalin A with fragment A from diphtheria toxin. Proc. Natl. Acad. Sci. USA, 1978, 75, 5319-5323. (Pubitemid 9079785)
27. Chang, T.-M.; Dazord, A.; Neville Jr, D.M. Artificial hybrid protein containing a toxic protein fragment and a cell membrane receptor-binding moiety in a disulfide conjugate I Synthesis of diphtheria toxin fragment A-S-S-human placental lactogen with methyl-5-bromovalerimidate. J. Biol. Chem., 1977, 252, 1505-1514. (Pubitemid 8047761)
28. Hiróoka, T.; Maassen, D.; Berger, P.; Boime, I. Disulfide bond mutations in follicle-stimulating hormone result in uncoupling of biological activity from intracellular behaviour. Endocrinology, 2000, 141, 4751-4756. (Pubitemid 32055155)
29. Mu, Y.; Nodwell, M.; Pace, J.L.; Shaw, J.-P.; Judice, J.K. Vancomycin disulfide derivatives as antibacterial agents. Bioorg. Med. Chem., 2004, 14, 735-738. (Pubitemid 38114862)
30. Perez, H.A.; Rosa, M.D.L.; Apitz, R. In vivo activity of ajoene against rodent malaria. Antimicrob. Agents Chemoth., 1994, 38, 337-339. (Pubitemid 24054257)
31. Yoshida, S., Kasuga, S.; Hayashi, N.; Ushiroguchi, T.; Matsuura, H.; Nakagawa, S. Antifungal activity of ajoene derived from garlic. Appl. Environ. Microbiol., 1987, 53, 615-617. (Pubitemid 17017558)
32. Block, E.; Ahamad, S.J.; Jain, M.K., Crecely, R.W.; Apitz-Castro, R.; Curz, M.R. (E,Z)-Ajoene: A potent antithrombotic agent from Garlic. J. Am. Chem. Soc., 1986, 108, 7045-7055.
33. Naganawa, R.; Iwata, N.; Ishikawa, K.; Fukuda, H.; Fujino, T.; Suzuki, A. Inhibation of microbial growth by ajoene , A sulfurcontaining compound derived from garlic. Appl. Environ. Microbiol., 1996, 63, 4238-4242.
34. Atta-Ur-Rahman, Choudhary, M.I. Recent studies on bioactive natural products. Pure Appl. Chem., 1999, 71, 1079-1081
35. Ledezma E.; Jorquera, A.; Bendezú, H.; Vivas, J.; Péres, G. Antiproliferative and leishmanicidal effect of ajoene on various Leishmania species; Ultrastructural study. Parasitol Res., 2002, 88, 748-753 and references quoted therein. (Pubitemid 34762328)
36. Khan, K.M.; Ali, M.; Taha, M.; Perveen, S.; Choudhary, M.I.; Voelter. W. An expedient and selective approach towards disulfides using sodium bromate/sodium hydrogen sulfite reagent. Lett. Org. Chem., 2008, 5, 432-434.
37. Khan, K.M.; Taha, M.; Ali, M.; Perveen, S. A mild and alternative approach towards symmetrical disulfides using H3IO5/NaHSO3 combination. Lett. Org. Chem., 2009, 6, 319-320.
38. Khan, K.M.; Taha, M.; Rahim, F.; Ali, M.; Jamil, W.; Perveen, S.; Choudhary, M.I. An improved method for the synthesis of disulfides by periodic acid and sodium hydrogen sulfite in water. Lett. Org. Chem., 2010, 7, 0000.
39. Pervez, H.; Manzoor, N.; Yaqub, M.; Khan, A.; Khan, K.M.; Nasim, Faiz-ul-Hassan; Choudhary, M.I. Synthesis and urease inhibitory properties of some new N-4-substituted 5-nitroisatin-3-thiosemicarbazones. Lett. Drug Design Discov., 2010, 7, 102-108.
40. Khan, K.M.; Khan, M.; Ali, M.; Taha, M.; Rasheed, S.; Perveen, S.; Choudhary, M.I. Synthesis of bis-schiff bases of isatins and their antiglycation activity. Bioorg. Med.l Chem., 2009, 17, 7795-7801.
41. Khan, K.M.; Fatima, N.; Rasheed, M.; Jalil, S.; Ambreen, N.; Perveen, S.; Choudhary, M.I. 1,3,4-Oxadiazole-2(3H)-thione and its analogues: A new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors. Bioorg. Med. Chem., 2009, 17, 7816-7822.
42. Khan, K.M.; Ahmad, A.; Ambreen, N.; Amyn, A.; Perveen, S.; Khan, S.A.; Choudhary, M.I. Schiff bases of 3-formylchromones as antibacterial, antifungal, and phytotoxic agents. Lett. Drug Des. Disco., 2009, 6, 363-373
43. Khan, K.M.; Ambreen, N.; Hussain, S.; Perveen, S.; Choudhary, M.I. Schiff bases of 3-formylchromone as thymidine phosphorylase inhibitors. Bioorg. Med. Chem., 2009, 17, 2983-2988.
44. Khan, K.M.; Saeed, S.; Ali, M.; Gohar, M.; Zahid, J.; Khan, A.; Perveen, S.; Choudhary, M.I. Unsymmetrically disubstituted urea derivatives: A potent class of antiglycating agents. Bioorg. Med. Chem., 2009, 17, 2447-2451
45. Pervez, H.; Chohan, Z.H.; Ramzan, M.; Nasim, Faiz-ul-Hassan; Khan K.M. Synthesis and biological evaluation of some new N4-substituted isatin-3-thiosemicarbazones. J. Enzyme Inhib. Med. Chem., 2009, 24, 437-446.